Multi-million-pound UK-wide research into cancer immunotherapy
The Francis Crick Institute and The Royal Marsden NHS Foundation [...]
ASTRO 2024: SABR for primary kidney cancer – Is it ready for ‘primetime’?
In this presentation at the 2024 American Society for Radiation [...]
Clinical impact of the CARMENA trial on cytoreductive nephrectomy in the USA
A recent study looked at whether the use of cytoreductive [...]
Kidney Cancer Highlights from ESMO 2024
This year’s European Society for Medical Oncology (ESMO) Congress was [...]
Pazopanib plus bevacizumab shows promise as a first-line treatment for kidney cancer
Results from a phase 2 study of pazopanib alternated with [...]
Biopsy of small renal masses leads to fewer radical nephrectomies
This study looks at how how the biopsy of small [...]
89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Intermittent immunotherapy in patients with metastatic kidney cancer
The combination of ipilimumab/nivolumab is approved for patients as a [...]
Belzutifan available on the NHS for patients with VHL disease
We are delighted to announce that the National Institute for [...]
Belzutifan compared to everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
